PineBridge Investments’s Medicines Co MDCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-22,146
Closed -$1.88M 1116
2019
Q4
$1.88M Sell
22,146
-35,674
-62% -$2.38M 0.03% 385
2019
Q3
$2.89M Buy
57,820
+3,180
+6% +$127K 0.05% 322
2019
Q2
$1.99M Buy
54,640
+13,474
+33% +$440K 0.03% 363
2019
Q1
$1.15M Sell
41,166
-13,109
-24% -$309K 0.02% 506
2018
Q4
$1.04M Buy
54,275
+2,483
+5% +$57.8K 0.02% 506
2018
Q3
$1.55M Sell
51,792
-5,634
-10% -$212K 0.03% 461
2018
Q2
$2.11M Sell
57,426
-8,256
-13% -$268K 0.05% 356
2018
Q1
$2.16M Sell
65,682
-12,866
-16% -$402K 0.05% 340
2017
Q4
$2.15M Buy
78,548
+22,664
+41% +$698K 0.06% 332
2017
Q3
$2.07M Sell
55,884
-31
-0.1% -$1.14K 0.05% 298
2017
Q2
$2.13M Buy
55,915
+12,874
+30% +$573K 0.06% 262
2017
Q1
$2.1M Buy
43,041
+12,343
+40% +$563K 0.06% 289
2016
Q4
$1.04M Buy
30,698
+21,852
+247% +$775K 0.03% 394
2016
Q3
$333K Buy
8,846
+23
+0.3% +$867 0.01% 353
2016
Q2
$297K Buy
8,823
+338
+4% +$11.9K 0.02% 374
2016
Q1
$270K Sell
8,485
-836
-9% -$27.3K 0.01% 384
2015
Q4
$348K Buy
9,321
+920
+11% +$34.8K 0.02% 365
2015
Q3
$319K Buy
8,401
+787
+10% +$27.6K 0.01% 384
2015
Q2
$217K Sell
7,614
-9,375
-55% -$261K 0.01% 475
2015
Q1
$476K Buy
16,989
+2,129
+14% +$59.8K 0.02% 441
2014
Q4
$411K Buy
14,860
+899
+6% +$22.3K 0.02% 453
2014
Q3
$312K Buy
13,961
+3,884
+39% +$98.6K 0.01% 491
2014
Q2
$293K Sell
10,077
-6,215
-38% -$166K 0.01% 437
2014
Q1
$463K Sell
16,292
-1,245
-7% -$41.2K 0.02% 459
2013
Q4
$677K Buy
17,537
+10,494
+149% +$375K 0.02% 389
2013
Q3
$236K Buy
7,043
+659
+10% +$21K 0.01% 461
2013
Q2
$197K Buy
+6,384
New +$214K 0.01% 488

Other funds holding MDCO

PineBridge Investments's MDCO Position: Q1 2020 in Review

PineBridge Investments sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 22,146 shares — an estimated $1.88M sold.

PineBridge Investments first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $2.89M in Q3 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • PineBridge Investments reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • PineBridge Investments sold 22,146 Medicines Co shares in Q1 2020, an estimated $1.88M.
  • PineBridge Investments first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
  • PineBridge Investments's Medicines Co position peaked at $2.89M in Q3 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on PineBridge Investments's 13F filing for Q1 2020, filed 14 May 2020.